← All Sponsors
SPONSOR

Stoke Therapeutics, Inc

Total Trials
1
Recruiting
1
Phases
Phase 3
Conditions studied: Dravet Syndrome
NCT06872125 Phase 3
Recruiting

A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome

Dravet Syndrome
United States, Japan, United Kingdom View Trial →